Supplementary figures from Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial

MLA

Shun Lu, et al. Supplementary Figures from Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22486836.v1.

APA

Shun Lu, Yiping Zhang, Zhijian Sun, Chan Gao, Ting Bei, Chunwei Xu, Wenxian Wang, Feng Hua, Xiaoyu Wu, Shenpeng Ying, Yuping Li, Jianjin Huang, Shi-Qing Chen, Dongqing Lv, & Zhengbo Song. (2023). Supplementary figures from Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial. https://doi.org/10.1158/1078-0432.22486836.v1

Chicago

Shun Lu, Yiping Zhang, Zhijian Sun, Chan Gao, Ting Bei, Chunwei Xu, Wenxian Wang, et al. 2023. “Supplementary Figures from Pyrotinib in Patients with HER2-Amplified Advanced Non–Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm Trial,” March. doi:10.1158/1078-0432.22486836.v1.